Suche
Mein Konto
40 years of neurosurgery in Fulda: A milestone in medicine!
The Neurosurgery Clinic at the Fulda Hospital is celebrating 40 years of cutting-edge medicine with innovative treatments and interdisciplinary collaboration.
40 years of neurosurgery in Fulda: A milestone in medicine!
The Neurosurgery Clinic at Fulda Hospital is celebrating an impressive anniversary: 40 years of cutting-edge medicine! Since it opened in 1984, the clinic has developed into one of the leading facilities for neurosurgical treatment in Germany. “We are proud of what we have achieved over the past 40 years,” emphasized Priv.-Doz. Dr. Thomas Menzel at the anniversary celebration and highlighted the tireless commitment of the entire team, which fights every day for the best possible patient care.
The celebrations offered a fascinating look back at the development of neurosurgery in Germany. Prof. Dr. Hartmut Collmann, an expert in the field, and Prof. Dr. Hans-Peter Richter, the clinic's founder, reported on its humble beginnings. The clinic opened in 1984 at a cost of 2.3 million DM and developed rapidly. A new operating room was put into operation as early as 1987, and the average length of stay for patients was reduced from 16.6 days to 9.5 days within just four years - proof of the clinic's efficiency.
A wide range of services
Today the clinic offers a comprehensive range of neurosurgical services that is constantly evolving. The focus is on brain tumor therapy, neurovascular surgery and complex spine surgery. What is particularly noteworthy is the clinic's worldwide recognition for its expertise in the care of patients with auditory brainstem implants. Prof. Dr. Robert Behr has treated over 70 children from more than 20 countries who were born without an auditory nerve. “Many patients are more than grateful to Prof. Dr. Behr,” says Menzel.
The clinic has also established close collaboration with various specialist departments, particularly in the Skull Base Center, which was founded in 2006. This interdisciplinary cooperation has significantly improved the quality of treatment. Prof. Dr. Stefan Grau, the current director, emphasizes that the treatment is not only aimed at survival, but also focuses on the patient's quality of life. Advances in imaging and intraoperative technologies enable more precise and gentler procedures that directly benefit patients.